Company Filing History:
Years Active: 2014
Title: Cecilia Oderda: Innovator in Pharmaceutical Composition
Introduction
Cecilia Oderda is a notable inventor based in Vésenaz, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel polymer conjugates. Her work focuses on addressing kinase-associated pathologies, which are critical in the medical field.
Latest Patents
Cecilia Oderda holds a patent for "Polymer conjugates of K-252A and derivatives thereof." This invention relates to innovative polymer conjugates that are useful for preparing pharmaceutical compositions aimed at preventing, alleviating, and treating various kinase-associated pathologies. Specifically, her invention targets neurological disorders, dermal pathologies such as psoriasis, and NGF-related pain. The polymer used in her conjugates is polyethylene glycol or methoxy-polyethylene glycol.
Career Highlights
Cecilia is associated with Creabilis Therapeutics S.p.a., where she applies her expertise in pharmaceutical innovations. Her work has the potential to significantly impact the treatment of various medical conditions, enhancing the quality of life for many patients.
Collaborations
Cecilia has collaborated with notable colleagues, including Silvio Traversa and Raffaella Bagnod. These partnerships have contributed to the advancement of her research and the development of her patented inventions.
Conclusion
Cecilia Oderda is a pioneering inventor whose work in polymer conjugates is paving the way for new pharmaceutical treatments. Her contributions are vital in the ongoing fight against complex medical conditions.